<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="6005">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01070693</url>
  </required_header>
  <id_info>
    <org_study_id>TYH1333</org_study_id>
    <nct_id>NCT01070693</nct_id>
  </id_info>
  <brief_title>Lichtenstein Patch or Prolene Hernia System (PHS) for Inguinal Hernia Repair</brief_title>
  <official_title>Randomized Clinical Trial of Lichtenstein Patch or Prolene Hernia System for Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <authority>Finland: Data Protection Board</authority>
    <authority>Finland: Ethics Committee</authority>
    <authority>Finland: Finnish Medicines Agency</authority>
    <authority>Finland: Ministry of Social Affairs and Health</authority>
    <authority>Finland: National Advisory Board on Health Care Ethics</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This randomised prospective study was designed to compare the convalescence and the
      long-term sequelae in inguinal hernia repair with either a bilayer mesh as devised by
      Gilbert (Prolene Hernia SystemÂ®) or an onlay mesh applied according to Lichtenstein.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">January 2005</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Long-term Sequelae</measure>
    <time_frame>5 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Any pain at five years</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Chronic Pain</condition>
  <arm_group>
    <arm_group_label>Prolene Hernia System device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inguinal hernia repair either with a bilayer mesh (PHS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lichtenstein</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Inguinal hernia repair with the Lichtenstein technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Open mesh inguinal hernia repair</intervention_name>
    <description>Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique</description>
    <arm_group_label>Prolene Hernia System device</arm_group_label>
    <arm_group_label>Lichtenstein</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prolene Hernia System</intervention_name>
    <description>Prolene Hernia System</description>
    <arm_group_label>Prolene Hernia System device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Lichtenstein technique</intervention_name>
    <description>Lichtenstein technique</description>
    <arm_group_label>Lichtenstein</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Uni- or bilateral

          -  Primary or recurrent

        Exclusion Criteria:

          -  body-mass index over 40kg/m2, severe co-morbidities
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Helsinki University Central Hospital</name>
      <address>
        <city>Espoo</city>
        <zip>07430</zip>
        <country>Finland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 2, 2013</lastchanged_date>
  <firstreceived_date>February 17, 2010</firstreceived_date>
  <firstreceived_results_date>December 2, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Jaana Vironen</investigator_full_name>
    <investigator_title>Consultant</investigator_title>
  </responsible_party>
  <keyword>Inguinal hernia</keyword>
  <keyword>Open mesh repair</keyword>
  <keyword>Long term outcome</keyword>
  <keyword>Recurrence</keyword>
  <keyword>Discomfort</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Included were 300 adult patients (282 men, 18 women) referred for elective repair having unilateral or bilateral inguinal hernias. Study period: September 2001 - January 2004, outpatient unit of Jorvi Hospital (Helsinki University Central Hospital, Espoo, Finland).</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Prolene Hernia System Device</title>
          <description>Inguinal hernia repair either with a bilayer mesh (PHS)</description>
        </group>
        <group group_id="P2">
          <title>Lichtenstein</title>
          <description>Inguinal hernia repair with the Lichtenstein technique</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="150"/>
                <participants group_id="P2" count="149"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="122"/>
                <participants group_id="P2" count="110"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="28"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Prolene Hernia System Device</title>
          <description>Inguinal hernia repair either with a bilayer mesh (PHS)</description>
        </group>
        <group group_id="B2">
          <title>Lichtenstein</title>
          <description>Inguinal hernia repair with the Lichtenstein technique</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="150"/>
                <measurement group_id="B2" value="149"/>
                <measurement group_id="B3" value="299"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="46" lower_limit="19" upper_limit="72"/>
                <measurement group_id="B2" value="47" lower_limit="20" upper_limit="70"/>
                <measurement group_id="B3" value="46" lower_limit="19" upper_limit="72"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="10"/>
                <measurement group_id="B2" value="8"/>
                <measurement group_id="B3" value="18"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="140"/>
                <measurement group_id="B2" value="141"/>
                <measurement group_id="B3" value="281"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Finland</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="150"/>
                <measurement group_id="B2" value="149"/>
                <measurement group_id="B3" value="299"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Long-term Sequelae</title>
        <description>Any pain at five years</description>
        <time_frame>5 years</time_frame>
        <safety_issue>No</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>Prolene Hernia System Device</title>
            <description>Inguinal hernia repair either with a bilayer mesh (PHS)
Open mesh inguinal hernia repair: Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique
Prolene Hernia System: Prolene Hernia System</description>
          </group>
          <group group_id="O2">
            <title>Lichtenstein</title>
            <description>Inguinal hernia repair with the Lichtenstein technique
Open mesh inguinal hernia repair: Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique
Lichtenstein technique: Lichtenstein technique</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="122"/>
                  <measurement group_id="O2" value="110"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Long-term Sequelae</title>
            <description>Any pain at five years</description>
            <units>percentage of participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="10"/>
                  <measurement group_id="O2" value="13"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Prolene Hernia System Device</title>
          <description>Inguinal hernia repair either with a bilayer mesh (PHS)
Open mesh inguinal hernia repair: Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique
Prolene Hernia System: Prolene Hernia System</description>
        </group>
        <group group_id="E2">
          <title>Lichtenstein</title>
          <description>Inguinal hernia repair with the Lichtenstein technique
Open mesh inguinal hernia repair: Inguinal hernia repair either with the bilayer mesh or the Lichtenstein technique
Lichtenstein technique: Lichtenstein technique</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="149"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="149"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Georgios Pierides</name_or_title>
      <organization>Helsinki University Central Hospital</organization>
      <phone>+358 9 4711</phone>
      <email>georgios.pierides@hus.fi</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
